Search

everythinglearnresearchcommunity

for

Search:↓

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Marijuana use may be linked to lower TSH levels, but the exact cause is unclear.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

Finasteride reduces prostate size and PSA levels in young patients.

Higher PSA levels can indicate prostate cancer, but there's overlap with non-cancerous conditions.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Finasteride improves urinary symptoms and quality of life in BPH patients, especially with larger prostate size.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Finasteride reduces certain hormone levels to treat prostate issues.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Dendrobium sabin flower extract may help reduce skin aging from UV exposure.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

Keratin-gelatin film improves wound healing in pets better than bFGF-gelatin.

Keratin-gelatin film improves wound healing in dogs and cats.

Shorter PSADT after prostate surgery is linked to higher risk of death.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

A semi-automated system can effectively help choose emulsion ingredients, simplifying the creation of medicinal and cosmetic products.